1. Lechner, M, Chandrasekharan, D, Jumani, KLiu J, Gane S, Lund VJ, et al. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers—a systematic review of the literature, case series, and recommendations for clinical assessment and management. Rhinology. 2020; 58(4):394–399.
Google Scholar | Medline2. Vaira, LA, Salzano, G, Deiana, GDe Riu G. Anosmia and ageusia: common findings in COVID-19 patients. Laryngoscope. 2020; 130:1787.
Google Scholar | Crossref | Medline3. Yan, CH, Faraji, F, Prajapati, DPBoone CE, DeConde AS. Association of chemosensory dysfunction and Covid-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol. 2020; 10(7):806–813.
Google Scholar | Crossref | Medline4. Lechien, JR, Chiesa-Estomba, CM, De Siati, DRHoroi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020; 277(8):2251–2261.
Google Scholar | Crossref | Medline5. Moein, ST, Hashemian, SMR, Mansourafshar, BKhorram-Tousi A, Tabarsi P, Doty RL. Smell dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol. 2020; 10(8):944–950.
Google Scholar | Crossref | Medline6. Parma, V, Ohla, K, Veldhuizen, MGNiv MY, Kelly CE, Bakke AJ, et al. More than smell - COVID-19 is associated with severe impairment of smell, taste, and chemesthesis. Chem Senses. 2020; 45(7):609–622.
Google Scholar | Crossref | Medline7. Menni, C, Valdes, AM, Freidin, MBSudre CH, Nguyen LH, Drew DA, et al. Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat Med. 2020; 26(7):1037–1040.
Google Scholar | Crossref | Medline8. Hummel, T, Whitcroft, KL, Andrews, P, Altundag A, Cinghi C, Costanzo RM, et al. Position paper on olfactory dysfunction. Rhinol Suppl. 2017; 54(26):1–30.
Google Scholar | Crossref | Medline9. Damm, M, Temmel, A, Welge-Lüssen, A, Eckel HE, Kreft MP, Klussmann JP, et al. [Olfactory dysfunctions. Epidemiology and therapy in Germany, Austria and Switzerland]. Hno. 2004; 52(2):112–120.
Google Scholar | Crossref | Medline10. Philpott, CM. Smell and taste disorders in the UK: First experiences with a specialised smell and taste outpatient clinic. Bull Bull. 2014; 96(5):156–159.
Google Scholar | Crossref11. Frasnelli, J, Landis, BN, Heilmann, S, Hauswald B, Hüttenbrink KB, Lacroix JS, et al. Clinical presentation of qualitative olfactory dysfunction. Eur Arch Otorhinolaryngol. 2004; 261(7):411–415.
Google Scholar | Crossref | Medline12. Philpott, CM, Boak, D. The impact of olfactory disorders in the United Kingdom. Chem Senses. 2014; 39(8):711–718.
Google Scholar | Crossref | Medline13. Erskine, SE, Philpott, CM. An unmet need: patients with smell and taste disorders. Clin Otolaryngol. 2020; 45(2):197–203.
Google Scholar | Crossref | Medline14. Liu, D, Sabha, M, Damm, MPhilpott C, Oleszkiewicz A, Haehner A, et al. Parosmia is associated with relevant olfactory recovery after olfactory training. Laryngoscope. 2021;131(3):618–623.
Google Scholar15. Reden, J, Maroldt, H, Fritz, AZahnert T, Hummel T. A study on the prognostic significance of qualitative olfactory dysfunction. Eur Arch Otorhinolaryngol. 2007; 264(2):139–144.
Google Scholar | Crossref | Medline16. Saltagi, MZ, Rabbani, CC, Ting, JYHiggins TS. Management of long-lasting phantosmia: a systematic review. Int Forum Allergy Rhinol. 2018; 8(7):790–796.
Google Scholar | Crossref | Medline17. List of abstracts from the thirty-second annual meeting of the association for chemoreception sciences. Chem Senses. 2010; 35:627–644.
Google Scholar | Crossref18. Leopold, D. Distortion of olfactory perception: diagnosis and treatment. Chem Senses. 2002; 27(7):611–615.
Google Scholar | Crossref | Medline19. Ball, S, Boak, D, Dixon, JCarrie S, Philpott C. Barriers to accessing healthcare in patients with olfactory and gustatory disorders [published online ahead of print June 22, 2020]. Authorea. 2020. doi:10.22541/au.159285606.60833639
Google Scholar20. Henkin, RI, Velicu, I, Schmidt, L. An open-label controlled trial of theophylline for treatment of patients with hyposmia. Am J Med Sci. 2009; 337(6):396–406.
Google Scholar | Crossref | Medline21. Pierre, B, Paul, A, Patrick, FDavid M. Distorted odorant perception: analysis of a series of 56 patients with parosmia. Arch Otolaryngol Head Neck Surg. 2005; 131(2):107–112.
Google Scholar